Clinical Trial

Botulinum Neurotoxin for Children With CP: a Delicate Balance Between Clinical Benefits and Muscular Harm

Study acronym: Bo-Balance
Recruiting
View on ClinicalTrials.gov →
Summary
A cross-sectional design study will be carried out to explore the morphological muscle properties and alterations in muscle composition on a macroscopic level in children with spastic cerebral palsy (CP). Muscle composition will be assessed using quantitative Magnetic Resonance Imaging (qMRI) and shear wave elastography (SWE), while macroscopic muscle size properties will be evaluated through 'Three-dimensional freehand ultrasound (3DfUS).
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-05-16; most recent amendment 2026-04-28.
Trial Details
NCT Number NCT06991725
Lead Sponsor Universitaire Ziekenhuizen KU Leuven
Conditions Spastic Cerebral Palsy (sCP)
Enrollment 51 participants
Start Date 2025-02-03
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-29